ARTICLE | Company News
Aqua Pharmaceuticals, GlaxoSmithKline sales and marketing update
June 17, 2013 7:00 AM UTC
Aqua acquired U.S. rights to Verdeso 0.05% desonide foam from GlaxoSmithKline's Stiefel Laboratories Inc. subsidiary. The low-potency topical steroid formulated with 0.05% desonide in emollient foam...